S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
Ulta Issues A Beautiful FY Outlook, But Is the Stock A Buy Now?
Microsoft strikes 10-year deal with Nintendo on Call of Duty
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Could trawler cams help save world's dwindling fish stocks?
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
Ulta Issues A Beautiful FY Outlook, But Is the Stock A Buy Now?
Microsoft strikes 10-year deal with Nintendo on Call of Duty
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Could trawler cams help save world's dwindling fish stocks?
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
Ulta Issues A Beautiful FY Outlook, But Is the Stock A Buy Now?
Microsoft strikes 10-year deal with Nintendo on Call of Duty
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Could trawler cams help save world's dwindling fish stocks?
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
Want To Catch The Next Hot Investing Trend (Look Inside?) (Ad)
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
Ulta Issues A Beautiful FY Outlook, But Is the Stock A Buy Now?
Microsoft strikes 10-year deal with Nintendo on Call of Duty
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Could trawler cams help save world's dwindling fish stocks?
NASDAQ:MGTA

Magenta Therapeutics ESG Rating & Sustainability Data

$1.23
+0.04 (+3.36%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.15
$1.24
50-Day Range
$1.04
$1.59
52-Week Range
$0.92
$5.86
Volume
63,666 shs
Average Volume
259,273 shs
Market Capitalization
$74.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

Key ESG Takeaways for Magenta Therapeutics

The keytakeaways are AI-generated and highlight the main contributors behind the net impact scores of Magenta Therapeutics. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Magenta Therapeutics seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is driven by its Clinical research services for physical health and Preclinical research services for physical health products.
  • Magenta Therapeutics uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category is driven by its Clinical research services for physical health and Preclinical research services for physical health products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, Magenta Therapeutics would improve its net impact ratio by 1 percentage points.

MGTA Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+74.4%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+77.5%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+69.3%
Society First
Value set that emphasizes society impacts over other impacts.
+43.3%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+87.8%
Health First
Value set that emphasizes health impacts over other impacts.
+85.3%

Magenta Therapeutics ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.63
+1.63
+1.81
+1.81
+0.01
+0.01
-0.04
-0.04
+0.00
-0.00
+0.12
+0.13
+0.00
+0.00
+3.69
+3.69
-0.00
0.00
+0.00
-2.12
-2.12
-0.52
+5.30
+5.82
-0.12
+0.71
+0.83
0.00
+0.00
-0.01
+0.00
+0.01
-0.01
+0.30
+0.30
-0.36
-0.36
+0.00
-0.10
-0.10
+0.00
-0.02
-0.02
+0.00
-0.02
-0.02
+0.00
-0.35
-0.35
+0.00

Upright Model Version 0.6.0
ESG Data Last Updated: October 12, 2022


About Upright's Net Impact Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.













Magenta Therapeutics ESG Rating - Frequently Asked Questions

How is Magenta Therapeutics doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Magenta Therapeutics has a net impact ratio of 74.4%, indicating an overall positive sustainability impact. Magenta Therapeutics seems to create the most significant positive value in the categories of Physical diseases, Creating knowledge, and Taxes. Magenta Therapeutics uses resources or causes negative impacts mostly in the categories of Scarce human capital, Physical diseases, and GHG emissions. Learn more on the sustainability of Magenta Therapeutics.

This page (NASDAQ:MGTA) was last updated on 12/8/2022 by MarketBeat.com Staff